Parameter | Men | Women | Pvalue |
---|---|---|---|
Patients, n (%) | 402 (21%) | 1510 (79%) | Â |
Age at treatment start, years | 54.7 (13.7) | 54.6 (14.5) | 0.93 |
Disease duration, years | 14.7 (10.8) | 15.9 (11.2) | 0.06 |
ESR, mm/h | 30.1 (21.9) | 33.1 (23.3) | 0.022,3 |
CRP, mg/l | 25.5 (30.1) | 24.9 (31.4) | 0.73 |
Physician global assessment | 2.2 (0.8) | 2.3 (0.7) | 0.38 |
Patient global assessment | 54.3 (24.3) | 58.7 (24.1) | 0.00* |
Pain | 54.8 (23.9) | 56.9 (24.2) | 0.16 |
Swollen joint count | 9.1 (5.9) | 8.8 (5.5) | 0.36 |
Tender joint count | 7.8 (6.3) | 8.7 (6.1) | 0.013,4 |
HAQ | 1.13 (0.68) | 1.34 (0.68) | 0.003,4 |
DAS28 | 5.07 (1.37) | 5.39 (1.21) | 0.003,4 |
DAS28-CRP | 4.87 (1.25) | 5.06 (1.14) | 0.013,4 |
EQ-5D | 0.49 (0.36) | 0.50 (0.30) | 0.89 |